Fresenius SE And Subsidiary Upgraded To Investment Grade 'BBB-' On Financial Policy Confirmation; Outlook Stable

Based on recent statements to us, we now see increased debt leverage through large-scale acquisitions at Germany-based health care group Fresenius SE&Co. KGaA (FSE) and its subsidiary, Fresenius Medical Care AG&Co. KGaA (FME) as less likely. We are therefore raising our long-term corporate credit ratings on FSE and FME to 'BBB-', assigning an 'A-3' short-term rating, and affirming the 'BB+' ratings on the senior unsecured debt, as well as the 'BBB-' ratings on the senior secured debt. The stable outlook reflects our forecast for continuing profitable growth at both FSE and FME, combined with moderate increase in business investment. LONDON (Standard&Poor's) Jan. 16, 2015--Standard&Poor's Ratings Services said today that it had raised

...+ Based on recent statements to us, we now see increased debt leverage through large-scale acquisitions at Germany-based health care group Fresenius SE & Co. KGaA (FSE) and its subsidiary, Fresenius Medical Care AG & Co. KGaA (FME) as less likely. + We are therefore raising our long-term corporate credit ratings on FSE and FME to '###-', assigning an 'A-3' short-term rating, and affirming the '##+' ratings on the senior unsecured debt, as well as the '###-' ratings on the senior secured debt. + The stable outlook reflects our forecast for continuing profitable growth at both FSE and FME, combined with moderate increase in business investment. LONDON (Standard & Poor's) Jan. 16, 2015--Standard & Poor's Ratings Services said today that it had raised its long-term corporate credit rating on Germany-based health care group Fresenius SE & Co. KGaA (FSE) and its subsidiary, Fresenius Medical Care AG & Co. KGaA (FME) to '###-' from '##+'. The outlook is stable. We assigned an 'A-3' short-term...

Ratings Action